Margo Georgiadis

Apr 20, 2018

Ancestry announced today that it has appointed Margo Georgiadis as CEO and member of its board of directors. Georgiadis will join the company on May 10. She will succeed Howard Hochhauser, who served as interim CEO since Oct 2017. Hochhauser will return to his position as Ancestry's CFO and COO. Georgiadis previously served as CEO at Mattel, and prior to that as President, Americas at Google.

Breaking News

Plasmid Transfer Let Cholera Pathogen in Yemen Become Multidrug Resistant, Study Suggests
Harbinger Health Raises $140 Million in Series B Financing
BioMérieux's BioFire Defense Secures $18.8M US DoD Contract for Infectious Disease Testing
Biora Therapeutics Settles Claims of Misleading Genetic Testing Advertisements
Genetic Overlap Between Schizophrenia, Cardiovascular Disease Risk Uncovered by GWAS Analysis

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.